Table of Contents Author Guidelines Submit a Manuscript
International Journal of Alzheimer’s Disease
Volume 2011, Article ID 292593, 8 pages
http://dx.doi.org/10.4061/2011/292593
Research Article

Glutamate-Mediated Primary Somatosensory Cortex Excitability Correlated with Circulating Copper and Ceruloplasmin

1Laboratory for Electrophysiology for Translational neuroScience (LET'S), Istituto di Scienze e Tecnologie della Cognizione (ISTC), Consiglio Nazionale delle Ricerche (CNR), Fatebenefratelli Hospital Isola Tiberina, Rome, Italy
2Neurology, Department of Imaging, San Raffaele Cassino, Rome, Italy
3Department of Clinical Neuroscience, Institue of Neurology, Campus Bio-Medico of Rome University, Rome, Italy
4Department of Neuroscience and Imaging, G. D'Annunzio University, Chieti, Italy
5Associazione Fatebenefratelli per la Ricerca biomedica (AFaR), Department of Neuroscience, Fatebenefratelli Hospital Isola Tiberina, Rome, Italy

Received 15 May 2011; Revised 8 August 2011; Accepted 29 August 2011

Academic Editor: D. Larry Sparks

Copyright © 2011 Franca Tecchio et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Medalia, I. Galynker, and I. H. Scheinberg, “The interaction of motor, memory, and emotional dysfunction in Wilson's disease,” Biological Psychiatry, vol. 31, no. 8, pp. 823–826, 1992. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Roncagliolo, M. Garrido, T. Walter, P. Peirano, and B. Lozoff, “Evidence of altered central nervous system development in infants with iron deficiency anemia at 6 mo: delayed maturation of auditory brainstem responses,” American Journal of Clinical Nutrition, vol. 68, no. 3, pp. 683–690, 1998. View at Google Scholar · View at Scopus
  3. D. J. Waggoner, T. B. Bartnikas, and J. D. Gitlin, “The role of copper in neurodegenerative disease,” Neurobiology of Disease, vol. 6, no. 4, pp. 221–230, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. I. Bertini and A. Rosato, “Menkes disease,” Cellular and Molecular Life Sciences, vol. 65, no. 1, pp. 89–91, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. A. I. Bush and R. E. Tanzi, “Therapeutics for Alzheimer's disease based on the metal hypothesis,” Neurotherapeutics, vol. 5, no. 3, pp. 421–432, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Salustri, G. Barbati, R. Ghidoni et al., “Is cognitive function linked to serum free copper levels? A cohort study in a normal population,” Clinical Neurophysiology, vol. 121, no. 4, pp. 502–507, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Squitti, C. Salustri, M. Siotto et al., “Ceruloplasmin/transferrin ratio changes in Alzheimer's disease,” International Journal of Alzheimer's Disease, vol. 2011, Article ID 231595, 6 pages, 2011. View at Publisher · View at Google Scholar
  8. H. Hochstrasser, P. Bauer, U. Walter et al., “Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease,” Neurology, vol. 63, no. 10, pp. 1912–1917, 2004. View at Google Scholar · View at Scopus
  9. H. Hochstrasser, J. Tomiuk, U. Walter et al., “Functional relevance of ceruloplasmin mutations in Parkinson's disease,” FASEB Journal, vol. 19, no. 13, pp. 1851–1853, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. J. P. Rubio, M. Bahlo, N. Tubridy et al., “Extended haplotype analysis in the HLA complex reveals an increased frequency of the HFE-C282Y mutation in individuals with multiple sclerosis,” Human Genetics, vol. 114, no. 6, pp. 573–580, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. S. V. Ramagopalan, M. Cukjati, M. Černilec et al., “Mutations in the hemochromatosis gene and the clinical outcome of multiple sclerosis,” Journal of Neuroimmunology, vol. 203, no. 1, pp. 104–107, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Percy, S. Moalem, A. Garcia et al., “Involvement of ApoE E4 and H63D in sporadic Alzheimer's disease in a folate-supplemented Ontario population,” Journal of Alzheimer's Disease, vol. 14, no. 1, pp. 69–84, 2008. View at Google Scholar · View at Scopus
  13. B. Z. Alizadeh, O. T. Njajou, M. R. Millán, A. Hofman, M. M. Breteler, and C. M. van Duijn, “HFE variants, APOE and Alzheimer's disease: findings from the population-based Rotterdam study,” Neurobiology of Aging, vol. 30, no. 2, pp. 330–332, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Giambattistelli, S. Bucossi, C. Salustri et al., “Effects of hemochromatosis and transferrin gene mutations on iron dyshomeostasis, liver dysfunction and on the risk of Alzheimer's disease,” Neurobiol Aging. In press. View at Publisher · View at Google Scholar
  15. V. Vlachova, H. Zemkova, and L. Vyklicky Jr., “Copper modulation of NMDA responses in mouse and rat cultured hippocampal neurons,” European Journal of Neuroscience, vol. 8, no. 11, pp. 2257–2264, 1996. View at Publisher · View at Google Scholar · View at Scopus
  16. M. L. Schlief, A. M. Craig, and J. D. Gitlin, “NMDA receptor activation mediates copper homeostasis in hippocampal neurons,” Journal of Neuroscience, vol. 25, no. 1, pp. 239–246, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. M. B. Youdim, D. Ben-Shachar, S. Yehuda, D. A. Levitsky, and J. M. Hill, “Putative biological mechanisms of the effect of iron deficiency on brain biochemistry and behavior,” American Journal of Clinical Nutrition, vol. 50, supplement 3, pp. 607–615, 1989. View at Google Scholar · View at Scopus
  18. V. N. Kharazia and R. J. Weinberg, “Glutamate in thalamic fibers terminating in layer IV of primary sensory cortex,” Journal of Neuroscience, vol. 14, no. 10, pp. 6021–6032, 1994. View at Google Scholar · View at Scopus
  19. M. A. Castro-Alamancos and B. W. Connors, “Thalamocortical synapses,” Progress in Neurobiology, vol. 51, no. 6, pp. 581–606, 1997. View at Publisher · View at Google Scholar · View at Scopus
  20. L. L. Porter, “Morphological characterization of a cortico-cortical relay in the cat sensorimotor cortex,” Cerebral Cortex, vol. 7, no. 2, pp. 100–109, 1997. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Fox, B. L. Schlaggar, S. Glazewski, and D. D. M. O'Leary, “Glutamate receptor blockade at cortical synapses disrupts development of thalamocortical and columnar organization in somatosensory cortex,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 11, pp. 5584–5589, 1996. View at Publisher · View at Google Scholar · View at Scopus
  22. R. S. Erzurumlu and P. C. Kind, “Neural activity: sculptor of 'barrels' in the neocortex,” Trends in Neurosciences, vol. 24, no. 10, pp. 589–595, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. C.-S. Lin, S. M. Lu, and D. E. Schmechel, “Glutamic acid decarboxylase immunoreactivity in layer IV of barrel cortex of rat and mouse,” Journal of Neuroscience, vol. 5, no. 7, pp. 1934–1939, 1985. View at Google Scholar
  24. J. C. Arezzo, H. G. Vaughan Jr., and A. D. Legatt, “Topography and intracranial sources of somatosensory evoked potentials in the monkey. II. Cortical components,” Electroencephalography and Clinical Neurophysiology, vol. 51, no. 1, pp. 1–18, 1981. View at Google Scholar · View at Scopus
  25. T. Allison, G. McCarthy, C. C. Wood, T. M. Darcey, D. D. Spencer, and P. D. Williamson, “Human cortical potentials evoked by stimulation of the median nerve. I. Cytoarchitectonic areas generating short-latency activity,” Journal of Neurophysiology, vol. 62, no. 3, pp. 694–710, 1989. View at Google Scholar · View at Scopus
  26. S. Vanni, B. Rockstroh, and R. Hari, “Cortical sources of human short-latency somatosensory evoked fields to median and ulnar nerve stimuli,” Brain Research, vol. 737, no. 1-2, pp. 25–33, 1996. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Gobbelé, T. D. Waberski, S. Kuelkens, W. Sturm, G. Curio, and H. Buchner, “Thalamic and cortical high-frequency (600 Hz) somatosensory-evoked potential (SEP) components are modulated by slight arousal changes in awake subjects,” Experimental Brain Research, vol. 133, no. 4, pp. 506–513, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. C. del Gratta, V. Pizzella, F. Tecchio, and G. L. Romani, “Magnetoencephalography—a noninvasive brain imaging method with 1 ms time resolution,” Reports on Progress in Physics, vol. 64, no. 12, pp. 1759–1814, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Sur, R. J. Nelson, and J. H. Kaas, “Representations of the body surface in cortical areas 3b and 1 of squirrel monkeys: comparisons with other primates,” The Journal of Comparative Neurology, vol. 211, no. 2, pp. 177–192, 1982. View at Google Scholar · View at Scopus
  30. J. T. Wall, J. H. Kaas, and M. Sur, “Functional reorganization in somatosensory cortical areas 3b and 1 of adult monkeys after median nerve repair: possible relationships to sensory recovery in humans,” Journal of Neuroscience, vol. 6, no. 1, pp. 218–233, 1986. View at Google Scholar · View at Scopus
  31. R. Kristeva-Feige, S. Rossi, V. Pizzella et al., “Neuromagnetic fields of the brain evoked by voluntary movement and electrical stimulation of the index finger,” Brain Research, vol. 682, no. 1-2, pp. 22–28, 1995. View at Publisher · View at Google Scholar
  32. R. C. Oldfield, “The assessment and analysis of handedness: the Edinburgh inventory,” Neuropsychologia, vol. 9, no. 1, pp. 97–113, 1971. View at Google Scholar · View at Scopus
  33. R. Squitti, D. Lupoi, P. Pasqualetti et al., “Elevation of serum copper levels in Alzheimer's disease,” Neurology, vol. 59, no. 8, pp. 1153–1161, 2002. View at Google Scholar · View at Scopus
  34. A. Abe, S. Yamashita, and A. Noma, “Sensitive, direct colorimetric assay for copper in serum,” Clinical Chemistry, vol. 35, no. 4, pp. 552–554, 1989. View at Google Scholar · View at Scopus
  35. B. S. Skikne, “Measuring iron-dextran in serum: is it important?” Clinical Chemistry, vol. 36, no. 10, p. 1711, 1990. View at Google Scholar · View at Scopus
  36. P. L. Wolf, “Ceruloplasmin: methods and clinical use,” Critical Reviews in Clinical Laboratory Sciences, vol. 17, no. 3, pp. 229–245, 1982. View at Google Scholar · View at Scopus
  37. T. Higgins, “Novel chromogen for serum iron determinations,” Clinical Chemistry, vol. 27, no. 9, pp. 1619–1620, 1981. View at Google Scholar · View at Scopus
  38. J. M. Walshe, “Wilson's disease: the importance of measuring serum caeruloplasmin non-immunologically,” Annals of Clinical Biochemistry, vol. 40, no. 2, pp. 115–121, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. F. Tecchio, P. M. Rossini, V. Pizzella, E. Cassetta, and G. L. Romani, “Spatial properties and interhemispheric differences of the sensory hand cortical representation: a neuromagnetic study,” Brain Research, vol. 767, no. 1, pp. 100–108, 1997. View at Publisher · View at Google Scholar · View at Scopus
  40. F. Zappasodi, P. Pasqualetti, M. Tombini et al., “Hand cortical representation at rest and during activation: gender and age effects in the two hemispheres,” Clinical Neurophysiology, vol. 117, no. 7, pp. 1518–1528, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. H. Tamano and A. Takeda, “Dynamic action of neurometals at the synapse,” Metallomics, vol. 3, no. 7, pp. 656–661, 2011. View at Publisher · View at Google Scholar
  42. T. Weiser and M. Wienrich, “The effects of copper ions on glutamate receptors in cultured rat cortical neurons,” Brain Research, vol. 742, no. 1-2, pp. 211–218, 1996. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Mathie, G. L. Sutton, C. E. Clarke, and E. L. Veale, “Zinc and copper: pharmacological probes and endogenous modulators of neuronal excitability,” Pharmacology and Therapeutics, vol. 111, no. 3, pp. 567–583, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. M. S. Horning and P. Q. Trombley, “Zinc and copper influence excitability of rat olfactory bulb neurons by multiple mechanisms,” Journal of Neurophysiology, vol. 86, no. 4, pp. 1652–1660, 2001. View at Google Scholar · View at Scopus
  45. A. Goldschmith, C. Infante, J. Leiva, E. Motles, and M. Palestini, “Interference of chronically ingested copper in long-term potentiation (LTP) of rat hippocampus,” Brain Research, vol. 1056, no. 2, pp. 176–182, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. M. L. Schlief and J. D. Gitlin, “Copper homeostasis in the CNS: a novel link between the NMDA receptor and copper homeostasis in the hippocampus,” Molecular Neurobiology, vol. 33, no. 2, pp. 81–90, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. M. L. Schlief, T. West, A. M. Craig, D. M. Holtzman, and J. D. Gitlin, “Role of the Menkes copper-transporting ATPase in NMDA receptor-mediated neuronal toxicity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 40, pp. 14919–14924, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. C. Acuña-Castillo, B. Morales, and J. P. Huidobro-Toro, “Zinc and copper modulate differentially the P2X4 receptor,” Journal of Neurochemistry, vol. 74, no. 4, pp. 1529–1537, 2000. View at Publisher · View at Google Scholar · View at Scopus
  49. J. Collinge, M. A. Whittington, K. C. L. Sidle et al., “Prion protein is necessary for normal synaptic function,” Nature, vol. 370, no. 6487, pp. 295–297, 1994. View at Publisher · View at Google Scholar · View at Scopus
  50. N. Sales, K. Rodolfo, R. Hassig, B. Faucheux, L. di Giamberardino, and K. L. Moya, “Cellular prion protein localization in rodent and primate brain,” European Journal of Neuroscience, vol. 10, no. 7, pp. 2464–2471, 1998. View at Publisher · View at Google Scholar · View at Scopus
  51. M. C. Linder, R. R. Bryant, and S. Lim, “Ceruloplasmin elevation and synthesis in rats with transplantable tumors,” Enzyme, vol. 24, no. 2, pp. 85–95, 1979. View at Google Scholar · View at Scopus
  52. P. Bielli and L. Calabrese, “Structure to function relationships in ceruloplasmin: a “moonlighting” protein,” Cellular and Molecular Life Sciences, vol. 59, no. 9, pp. 1413–1427, 2002. View at Publisher · View at Google Scholar · View at Scopus
  53. N. E. Hellman and J. D. Gitlin, “Ceruloplasmin metabolism and function,” Annual Review of Nutrition, vol. 22, pp. 439–458, 2002. View at Publisher · View at Google Scholar · View at Scopus
  54. G. J. Brewer, F. Askari, M. T. Lorincz et al., “Treatment of Wilson disease with ammonium tetrathiomolybdate. IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease,” Archives of Neurology, vol. 63, no. 4, pp. 521–527, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. R. Rao, I. Tkac, E. L. Townsend, K. Ennis, R. Gruetter, and M. K. Georgieff, “Perinatal iron deficiency predisposes the developing rat hippocampus to greater injury from mild to moderate hypoxia-ischemia,” Journal of Cerebral Blood Flow and Metabolism, vol. 27, no. 4, pp. 729–740, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. J. M. Wrigglesworth, N. Ioannidis, and P. Nicholls, “Spectrophotometric characterization of intermediate redox states of cytochrome oxidase,” Annals of the New York Academy of Sciences, vol. 550, pp. 150–160, 1988. View at Google Scholar · View at Scopus
  57. M. T. Wong-Riley, “Cytochrome oxidase: an endogenous metabolic marker for neuronal activity,” Trends in Neurosciences, vol. 12, no. 3, pp. 94–101, 1989. View at Google Scholar · View at Scopus
  58. J. Huttunen, E. Pekkonen, R. Kivisaari, T. Autti, and S. Kähkönen, “Modulation of somatosensory evoked fields from SI and SII by acute GABAA-agonism and paired-pulse stimulation,” NeuroImage, vol. 40, no. 2, pp. 427–434, 2008. View at Publisher · View at Google Scholar · View at Scopus
  59. T. Tarohda, M. Yamamoto, and R. Amamo, “Regional distribution of manganese, iron, copper, and zinc in the rat brain during development,” Analytical and Bioanalytical Chemistry, vol. 380, no. 2, pp. 240–246, 2004. View at Google Scholar · View at Scopus
  60. A. Al-Chalabi and P. N. Leigh, “Recent advances in amyotrophic lateral sclerosis,” Current Opinion in Neurology, vol. 13, no. 4, pp. 397–405, 2000. View at Publisher · View at Google Scholar · View at Scopus
  61. M. A. van Es, J. H. Veldink, C. G. J. Saris et al., “Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis,” Nature Genetics, vol. 41, no. 10, pp. 1083–1087, 2009. View at Publisher · View at Google Scholar · View at Scopus